Economic impact of switching from valsartan to other angiotensin receptor blockers in patients with hypertension

Author： Signorovitch J. Zhang J. Wu E.Q. Latremouille-Viau D. Yu A.P. Dastani H.B. Kahler K.H.

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.26, Iss.4, 2010-04, pp. : 849-860

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amlodipine and valsartan: calcium channel blockers/angiotensin II receptor blockers combination for hypertension

By Kjeldsen Sverre E Aksnes Tonje A de la Sierra Alex Ruilope Luis M

Therapy, Vol. 4, Iss. 1, 2007-01 ,pp. : 31-40

Future Medicine

Access to resources Recommend Favorite

Effect on blood pressure control of switching from valsartan monotherapy to losartan/hydrochlorothiazide in Asian patients with hypertension: results of a multicentre open-label trial

By Watanabe Luis A. Wei Meng Sun Ningling Kim Dongsoo Chiang Chern-En Ke Yuannan Tseng Chuen-Den Coloma Ricardo Vala M. Massaad R. Feig P. Guptha S.

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 1955-1964

Informa Healthcare

Access to resources Recommend Favorite

Can ACE Inhibitors and Angiotensin Receptor Blockers Be Detrimental in CKD Patients?

Nephron Clin Pract, Vol. 118, Iss. 4, 2011-03 ,pp. : c407-c419

Karger

Access to resources Recommend Favorite

From Evidence to Rationale: Cardiovascular Protection by Angiotensin II Receptor Blockers Compared with Angiotensin-Converting Enzyme Inhibitors

Cardiology, Vol. 117, Iss. 3, 2010-11 ,pp. : 163-173

Karger

Access to resources Recommend Favorite

Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy

By Neutel J.M.

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 213-222

Informa Healthcare

Access to resources Recommend Favorite